Russian Vaccine
-
{
- All
- News
- Videos
-
Russia Hopes Sputnik-V Vaccine Approval "Will Be Completed Soon" In India
- Monday April 12, 2021
- India News | Press Trust of India
Russia has said that it hopes that the Drug Controller General of India (DCGI) will soon complete the approval process for the Sputnik-V coronavirus vaccine after it was recommended for use in India by a committee of experts.
-
www.ndtv.com
-
17 Volunteers Given Sputnik V Vaccine During Clinical Trial In Pune
- Sunday December 6, 2020
- Pune News | Press Trust of India
A total of 17 volunteers have been administered Russia's Sputnik V coronavirus vaccine at a Pune hospital as part of the human clinical trials, doctors said today.
-
www.ndtv.com
-
First Batch Of Russia's Covid Vaccine Sputnik V Released Into Public
- Tuesday September 8, 2020
- World News | ANI
The first batch of Sputnik V vaccine against coronavirus, developed by Russia's Gamaleya National Research Center of Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF) has been released into civil circulation, regional deliveries are planned in the nearest future, the Russian Health Ministry informs.
-
www.ndtv.com
-
Russia Hopes Sputnik-V Vaccine Approval "Will Be Completed Soon" In India
- Monday April 12, 2021
- India News | Press Trust of India
Russia has said that it hopes that the Drug Controller General of India (DCGI) will soon complete the approval process for the Sputnik-V coronavirus vaccine after it was recommended for use in India by a committee of experts.
-
www.ndtv.com
-
17 Volunteers Given Sputnik V Vaccine During Clinical Trial In Pune
- Sunday December 6, 2020
- Pune News | Press Trust of India
A total of 17 volunteers have been administered Russia's Sputnik V coronavirus vaccine at a Pune hospital as part of the human clinical trials, doctors said today.
-
www.ndtv.com
-
First Batch Of Russia's Covid Vaccine Sputnik V Released Into Public
- Tuesday September 8, 2020
- World News | ANI
The first batch of Sputnik V vaccine against coronavirus, developed by Russia's Gamaleya National Research Center of Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF) has been released into civil circulation, regional deliveries are planned in the nearest future, the Russian Health Ministry informs.
-
www.ndtv.com